Jul 18 2025 This Week in Cardiology

Published Date: 19 Jul 2025

Finerenone, what not to consider when choosing treatment of AS, brain health after atrial fibrillation ablation, early rhythm control for AF, and Watchman reimbursement cuts are discussed by John Mandrola, MD, in this week’s podcast.

Read Full News

Latest News

Shorter, Scalable CBT Models Ease Chronic Pain in Two RCTs

Two randomized clinical trials suggest that brief, virtual, and self-directed CBT models can reduce pain interference and expand access to evidence-based chronic pain care.

Patients With Chronic Pain May Find Relief With IV Lidocaine

An intravenous infusion of lidocaine in patients with chronic pain is associated with clinically meaningful relief from pain and mild side effects, a study finds.

How Hypnosis Transformed Medicine in France

In 19th-century France, hypnosis moved from medical experiment to public spectacle, reshaping debates over mind, body, and control.

Can AI Save Doctors From Missed Diagnoses?

For AI to be useful, we must also tackle the problem of alert fatigue.

Knee Distraction Shows Promise in Severe Osteoarthritis

A novel knee distraction technique is drawing interest for severe osteoarthritis, with studies showing lasting symptom relief and tissue changes years later.

Sugammadex Linked to Lower Respiratory Risks After Endoscopy

Block reversal using sugammadex is associated with better respiratory outcomes than that using neostigmine in adults undergoing upper gastrointestinal endoscopic procedures, a study finds.

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Latest News

Two randomized clinical trials suggest that brief, virtual, and self-directed CBT models can reduce pain interference and expand access to evidence-based chronic pain care.

An intravenous infusion of lidocaine in patients with chronic pain is associated with clinically meaningful relief from pain and mild side effects, a study finds.

In 19th-century France, hypnosis moved from medical experiment to public spectacle, reshaping debates over mind, body, and control.

For AI to be useful, we must also tackle the problem of alert fatigue.

A novel knee distraction technique is drawing interest for severe osteoarthritis, with studies showing lasting symptom relief and tissue changes years later.

Block reversal using sugammadex is associated with better respiratory outcomes than that using neostigmine in adults undergoing upper gastrointestinal endoscopic procedures, a study finds.

News All Time

Smoking, Painkiller Usage Linked to Drug-Overuse Headache

Smoking and greater nicotine and analgesic dependence are tied to medication-overuse headache, psychological distress, and addiction-related traits, new research shows.

The Case for Investing in Children's Health Tech

Children receive less than 2% of digital health investment — a gap that experts say is already damaging adult health outcomes.

25 Great Summer Vacations for Doctors: 2026

Summer is here, so check out these intriguing destinations to spark up your off-duty time.

Why Is Sexual Health Still Overlooked in Chronic Pain Care?

Experts urge clinicians to address intimacy and sexual well-being routinely, noting that chronic pain often affects relationships, self-esteem, and quality of life.

Europe’s STI Surge: Is Fertility at Risk?

Gonorrhea and syphilis continue to rise across Europe, prompting renewed warnings about infertility, congenital infection, and missed diagnoses.

What Docs Love About Rural Medicine

Practicing rural medicine may not be right for every doctor, but for those who love it, it’s not just a career but a calling.

Can Continuous Blocks Cut Opioid Use After Knee Surgery?

A continuous adductor canal catheter block may not lower the use of opioids after knee replacement surgery compared with a single-injection block along with dexamethasone, a study finds.

Should Epinephrine Be Removed From Shockable Arrests?

Drs Robert Glatter and Peter Antevy argue that epinephrine may worsen outcomes in shockable cardiac arrest and explain why early defibrillation, DSED, and high-performance CPR should take priority.

Does Anesthesia Choice Affect Postpartum Depression Risk?

Mothers who receive neuraxial anesthesia during cesarean delivery have a lower risk for postpartum depression within 1 year than those who receive general anesthesia, a new study shows.

The Hidden Cost of Racial Bias in Medicine

From delayed diagnoses to unequal pain treatment, racial bias in medicine can shape care in ways clinicians may not even notice.

Jun 12 2026 This Week in Cardiology

Listener feedback, transcatheter tricuspid valve replacement, a new metabolic disease called CKM, the ARISE-FLUIDS Trial, the BIHCA trial, and temporal trends in ICD therapies are the topics John Mandrola, MD, discusses in this week’s podcast.

Conjugated Pneumococcal Vaccines Have Transformed Pediatrics

Rates of acute otitis media, acute sinusitis, lobar pneumonia, pneumococcal meningitis, and bacteremia decreased substantially after the introduction of the first pneumococcal vaccine in 2000.

Psoriasis Tied to Chronic Intense Pain, Multiple Pain Sites

A population-based study reports that psoriasis is associated with chronic pain at multiple sites and with high intensity even after ruling out known diagnoses of psoriatic arthritis.

Hydrofluoric Acid Burns: Why Clinicians Often Miss Them

Hydrofluoric acid burns may look deceptively mild at first, but delayed, disproportionate pain can signal a far more serious toxic injury.

Pain Becomes Key Criterion in Endometriosis Diagnosis

New medical guidelines propose diagnosing endometriosis based on reported pain as sufficient clinical evidence for treatment, potentially ending year long waits for treatment and validation.

First, Do No Harm. Then Press 'Record.'

The use of AI scribes is exploding in US healthcare systems, but there are patient consent issues behind ‘recording’ these visits. Dr Amy Faith Ho looks at the ramifications of this new technology.

Recommended News For You

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Smart exercise planning could boost recovery for people with cancer

Alternative Medicine for Breast Cancer: Study Raises Concern

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

Patients with head and neck cancer who cannot receive cisplatin now have new hope.

Recommended Articles For You

Clinical Methods in Hematology and Quality Improvement 

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection 

Gene Therapy for Hemophilia: A New Hope on the Horizon 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Inner Thoughts of Leonard Bernstein, the "Maestro".

2.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

3.

No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC

4.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

5.

A promising medication could slow brain tumors in children.

1.

Future-Ready Cancer Screening: What Every Clinician Should Know in 2025

2.

Cancer Evolution and Therapeutic Resistance: Mechanisms, Clinical Insights, and Emerging Strategies

3.

Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances

4.

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases

5.

Generative AI for Adaptive Oncology Trial Design

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

4.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

5.

Current Scenario of Cancer- The Incidence of Cancer in Men

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot